Four of the world’s leading geneticists, whose academic work had been cited over 50,000 times, shared a commitment to use genomics research to transform healthcare. In 2014 they formed a company to combine cutting-edge science with commercial delivery.
Genomics plc was born
Prof. Peter Donnelly
Founder & CEO
Prof. Gil McVean
Founder & Director
Dr. Chris Spencer
Founder & Head of Innovation
Dr. Gerton Lunter
We have built the world’s largest genomic database, which continues to expand in size and diversity every week. Our algorithms overcome the limitations of other methods, and are capable of working at an unprecedented scale of data to tell us how any one of millions of genetic variants affects thousands of molecular, cellular, physiological and disease traits. We use this powerful engine to find new drug targets for serious diseases, and to deliver precision health.
We deeply appreciate the contribution of millions of individuals who have participated in genomic research and researchers who have made their data widely available.
We’re backed by a diverse team of top investors who work with us to translate our scientific excitement and opportunity into commercial success.